卡瑞利珠单抗联合白蛋白紫杉醇二线治疗Ⅳ期肺大细胞神经内分泌癌 1 例及文献复习
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 416, doi. 10.3872/j.issn.1007-385x.2021.04.016
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2021 AND VI 28 AND IP 4
Results: 16
1
2
胃癌合并多原发癌的临床特征与治疗的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 410, doi. 10.3872/j.issn.1007-385x.2021.04.015
- By:
- Publication type:
- Article
3
血小板RNA在非小细胞肺癌中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 405, doi. 10.3872/j.issn.1007-385x.2021.04.014
- By:
- Publication type:
- Article
4
长链非编码RNA在宫颈癌中作用的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 398, doi. 10.3872/j.issn.1007-385x.2021.04.013
- By:
- Publication type:
- Article
5
嵌合抗原受体基因修饰T淋巴细胞治疗肺癌的研究进展和挑战.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 392, doi. 10.3872/j.issn.1007-385x.2021.04.012
- By:
- Publication type:
- Article
6
以肿瘤相关免疫细胞为标志物预测和评估抗PD-1/PD-L1疗效的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 384, doi. 10.3872/j.issn.1007-385x.2021.04.011
- By:
- Publication type:
- Article
7
干扰素诱导的穿膜蛋白家族在肿瘤中的作用及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 378, doi. 10.3872/j.issn.1007-385x.2021.04.010
- By:
- Publication type:
- Article
8
环状RNA FBXO11 靶向miR-376a-3p/SNRPB轴调控胃癌SNU-1 细胞的 增殖与凋亡.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 370, doi. 10.3872/j.issn.1007-385x.2021.04.009
- By:
- Publication type:
- Article
9
云南地区晚期非小细胞肺癌患者的基因突变及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 365, doi. 10.3872/j.issn.1007-385x.2021.04.008
- By:
- Publication type:
- Article
10
靶向抗PD-1/CD19 双特异性抗体的表达与活性鉴定.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 359, doi. 10.3872/j.issn.1007-385x.2021.04.007
- By:
- Publication type:
- Article
11
BRCA1 通过Wnt/β-catenin 通路对非小细胞肺癌H1650 细胞增殖、迁 移和侵袭的影响.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 353, doi. 10.3872/j.issn.1007-385x.2021.04.006
- By:
- Publication type:
- Article
12
miR-361-5p通过靶向CCND1 逆转胃癌SGC-7901 细胞奥沙利铂耐药性.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 346, doi. 10.3872/j.issn.1007-385x.2021.04.005
- By:
- Publication type:
- Article
13
人源IL-15 转基因NCG小鼠在CAR-NK细胞肿瘤治疗临床前评价中的 应用.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 339, doi. 10.3872/j.issn.1007-385x.2021.04.004
- By:
- Publication type:
- Article
14
miR-21 靶向PDCD4调控非小细胞肺癌A549 细胞的增殖与迁移.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 332, doi. 10.3872/j.issn.1007-385x.2021.04.003
- By:
- Publication type:
- Article
15
外泌体来源的miR-181a 促进胶质瘤的血管生成.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 325, doi. 10.3872/j.issn.1007-385x.2021.04.002
- By:
- Publication type:
- Article
16
精准医疗背景下晚期恶性黑色素瘤治疗的现状与进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 4, p. 317, doi. 10.3872/j.issn.1007-385x.2021.04.001
- By:
- Publication type:
- Article